IL15 and neoplasm: Several preclinical and early-phase clinical studies have demonstrated that IL-15 promotes homeostatic proliferation and supports long-term survival of CAR T and CAR NK cells, translating into improved tumor control in solid and hematologic malignancies [31,127].